Latest Breaking News On - Perspective therapeutics - Page 9 : comparemela.com

Perspective Commences Recruitment for Second Dose Escalation Cohorts in Clinical Studies of Two Lead Programs: [(212)Pb]VMT-α-NET and [(212)Pb]VMT01 -January 17, 2024 at 08:03 am EST

SEATTLE, Jan. 17, 2024 Perspective Therapeutics, Inc. , today announced that it began patient recruitment for the second dosing cohorts in clinical studies for both of its lead product.

United statesMarkus puhlmannDepartment of energyExchange commissionPerspective therapeutics incChief medical officerPerspective therapeuticMayo clinic rochesterPerspective therapeuticsTransition reportQuarterly report

Perspective Therapeutics, Inc : Perspective Commences Recruitment for Second Dose Escalation Cohorts in Clinical Studies of Two Lead Programs: [(212)Pb]VMT-a-NET and [(212)Pb]VMT01

Perspective Therapeutics, Inc : Perspective Commences Recruitment for Second Dose Escalation Cohorts in Clinical Studies of Two Lead Programs: [(212)Pb]VMT-a-NET and [(212)Pb]VMT01
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesMarkus puhlmannStefan klotterExchange commissionPerspective therapeutics incDepartment of energyChief medical officerPerspective therapeuticMayo clinic rochesterPerspective therapeuticsTransition reportQuarterly reportDie performance strategieAssets sie

Perspective Therapeutics Shares Rise 8 5% After Investment From Lantheus

By Ben Glickman Shares of Perspective Therapeutics rose early Tuesday after the company received an equity investment from Lantheus Holdings. The stock was.

New jerseyUnited statesBen glickmanLantheus holdingsPerspective therapeuticsArticle normalMedical equipment suppliesHealthcare life sciencesMedical diagnostic equipment suppliesMedical devices apparatusDiagnostic therapeutic devicesFinancial performanceShare price movement disruptionsOwnership changesAcquisitions mergers shareholdingsAcquisitions mergers

Perspective Therapeutics (CATX) Enters into Strategic Agreements with Lantheus (LNTH) Including Equity Investment, Co-Development Options

Perspective Therapeutics (CATX) Enters into Strategic Agreements with Lantheus (LNTH) Including Equity Investment, Co-Development Options
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New jerseyUnited statesMary anne heinoThijs spoorPerspective therapeutics incLantheus holdings incLantheus holdingsChief executive officerPerspective therapeutics

Perspective Therapeutics Enters into Strategic Agreements with Lantheus Including Equity Investment, Co-Development Options, and Expansion of Manufacturing Capability

Lantheus will have the option to negotiate an exclusive license to Perspective Therapeutics’ Pb212-VMT-α-NETLantheus will have the option to co-fund and negotiate an exclusive license for certain.

United statesNew jerseyMary anne heinoThijs spoorPerspective therapeutics incLantheus holdings incDepartment of energyExchange commissionPerspective therapeuticsPerspective therapeuticLantheus holdingsChief executive officerTransition reportQuarterly report